BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 885 filers reported holding BAXTER INTL INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $516,510 | -17.2% | 13,686 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $623,534 | +6.2% | 13,686 | -5.4% | 0.00% | 0.0% |
| Q1 2023 | $587,025 | -27.7% | 14,473 | -9.2% | 0.00% | -33.3% |
| Q4 2022 | $812,258 | -5.3% | 15,936 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $858,000 | -16.2% | 15,936 | 0.0% | 0.00% | -25.0% |
| Q2 2022 | $1,024,000 | -12.8% | 15,936 | +5.2% | 0.00% | 0.0% |
| Q1 2022 | $1,174,000 | -9.7% | 15,144 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $1,300,000 | +6.7% | 15,144 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $1,218,000 | -0.1% | 15,144 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $1,219,000 | -4.5% | 15,144 | 0.0% | 0.00% | -20.0% |
| Q1 2021 | $1,277,000 | +4.4% | 15,144 | -0.7% | 0.01% | 0.0% |
| Q4 2020 | $1,223,000 | -0.2% | 15,244 | 0.0% | 0.01% | 0.0% |
| Q3 2020 | $1,226,000 | -6.6% | 15,244 | 0.0% | 0.01% | -16.7% |
| Q2 2020 | $1,313,000 | +6.1% | 15,244 | 0.0% | 0.01% | -25.0% |
| Q1 2020 | $1,238,000 | -2.9% | 15,244 | 0.0% | 0.01% | +33.3% |
| Q4 2019 | $1,275,000 | -2.0% | 15,244 | +2.5% | 0.01% | -14.3% |
| Q3 2019 | $1,301,000 | +6.8% | 14,874 | 0.0% | 0.01% | +16.7% |
| Q2 2019 | $1,218,000 | +0.7% | 14,874 | 0.0% | 0.01% | 0.0% |
| Q1 2019 | $1,209,000 | +23.5% | 14,874 | 0.0% | 0.01% | 0.0% |
| Q4 2018 | $979,000 | -14.6% | 14,874 | 0.0% | 0.01% | 0.0% |
| Q3 2018 | $1,147,000 | +3.7% | 14,874 | -0.7% | 0.01% | 0.0% |
| Q2 2018 | $1,106,000 | +13.6% | 14,974 | 0.0% | 0.01% | +20.0% |
| Q1 2018 | $974,000 | +0.6% | 14,974 | 0.0% | 0.01% | 0.0% |
| Q4 2017 | $968,000 | +3.0% | 14,974 | 0.0% | 0.01% | 0.0% |
| Q3 2017 | $940,000 | +2.4% | 14,974 | -1.3% | 0.01% | 0.0% |
| Q2 2017 | $918,000 | +16.3% | 15,168 | -0.3% | 0.01% | +25.0% |
| Q1 2017 | $789,000 | +16.9% | 15,218 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $675,000 | -6.8% | 15,218 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $724,000 | +5.2% | 15,218 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $688,000 | +10.1% | 15,218 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $625,000 | +7.6% | 15,218 | 0.0% | 0.00% | +33.3% |
| Q4 2015 | $581,000 | +16.2% | 15,218 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $500,000 | -45.0% | 15,218 | +17.1% | 0.00% | -40.0% |
| Q2 2015 | $909,000 | +2.0% | 13,000 | 0.0% | 0.01% | +25.0% |
| Q1 2015 | $891,000 | -6.5% | 13,000 | 0.0% | 0.00% | -20.0% |
| Q4 2014 | $953,000 | +2.1% | 13,000 | 0.0% | 0.01% | +25.0% |
| Q3 2014 | $933,000 | -0.7% | 13,000 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $940,000 | -1.8% | 13,000 | 0.0% | 0.00% | -20.0% |
| Q1 2014 | $957,000 | -10.1% | 13,000 | -15.0% | 0.01% | 0.0% |
| Q4 2013 | $1,064,000 | -0.9% | 15,300 | -1.3% | 0.01% | 0.0% |
| Q2 2013 | $1,074,000 | – | 15,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |